Alnylam Pharmaceuticals (ALNY) Non-Current Deffered Revenue (2009 - 2024)
Alnylam Pharmaceuticals (ALNY) reported Non-Current Deffered Revenue of $1.01 million for Q3 2024, down 99.5% from $196.09 million a year earlier and down 57.9% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Non-Current Deffered Revenue (2009 - 2024) Analysis & Trends
At the end of FY2023, Alnylam Pharmaceuticals posted Non-Current Deffered Revenue of $188.18 million, down 2.9% from FY2022.
- Non-Current Deffered Revenue has a five-year compound annual growth rate of 233.2% (FY2018 to FY2023).
- By year, Non-Current Deffered Revenue came in at $193.79 million in FY2022 (+27.2%), $152.36 million in FY2021 (-32.3%), $225.09 million in FY2020 (-29.3%) and $318.38 million in FY2019.
- The Q3 2024 figure ranks as the lowest quarterly Non-Current Deffered Revenue since Q1 2019.
- Year over year, Non-Current Deffered Revenue has now declined in each of the last four quarters, with an average decline of 12.2% over the last eight quarters.
- The high point for year-over-year Non-Current Deffered Revenue in five years was Q3 2023 (growth of 47.5%); the low point was Q3 2024 (a decline of 99.5%).
- Per Business Quant data, the three quarters before Q3 2024 came in at $2.4 million (Q2 2024), $185.51 million (Q1 2024) and $188.18 million (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | - |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | - |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | - |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 185.51 Mn |
| Dec 31, 2023 | 188.18 Mn |
| Sep 30, 2023 | 196.09 Mn |
| Jun 30, 2023 | 194.13 Mn |
| Mar 31, 2023 | 191.26 Mn |
| Dec 31, 2022 | 193.79 Mn |
| Sep 30, 2022 | 132.93 Mn |
| Jun 30, 2022 | 175.34 Mn |
| Mar 31, 2022 | 157.67 Mn |
| Dec 31, 2021 | 152.36 Mn |
| Sep 30, 2021 | 177.12 Mn |
| Jun 30, 2021 | 202.39 Mn |
| Mar 31, 2021 | 208.12 Mn |
| Dec 31, 2020 | 225.09 Mn |
| Sep 30, 2020 | 265.71 Mn |
| Jun 30, 2020 | 281.53 Mn |
| Mar 31, 2020 | 306.12 Mn |
| Dec 31, 2019 | 318.38 Mn |
API Access
Alnylam Pharmaceuticals Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();